Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity

JL Jones, JA Anderson, C Phuah, E Fox, K Selmaj, D Margolin, S Lake, A Wilkins, D Webber, A Compston, AJ Coles

Research output: Contribution to journalArticle (Academic Journal)peer-review

136 Citations (Scopus)
Translated title of the contributionImprovement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity
Original languageEnglish
Pages (from-to)2232 - 2247
JournalBrain
Volume133
DOIs
Publication statusPublished - 2010

Cite this